Cost effectiveness of a point-of-care test for adenoviral conjunctivitis

American Journal of the Medical Sciences

Volumn 336, Issue 3, 2008, Pages 254-264

  Udeh, Belinda L ^a   Schneider, John E ^a   Ohsfeldt, Robert L ^b  

^a Health Economics Consulting Group LLC   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Adenoviral; Conjunctivitis; Cost effectiveness

Indexed keywords

ANTIBIOTIC AGENT; DRUG;

ADENOVIRUS; ANTIBIOTIC THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; MEDICAL CARE; POINT OF CARE TESTING; SOCIETY; TREATMENT INDICATION; UNITED STATES; UNNECESSARY PROCEDURE; VIRAL CONJUNCTIVITIS; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; ECONOMICS; HEALTH CARE COST; HOSPITAL INFORMATION SYSTEM; PREVALENCE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VIRUS INFECTION;

ADENOVIRUS INFECTIONS, HUMAN; COMPUTER SIMULATION; CONJUNCTIVITIS, VIRAL; COST-BENEFIT ANALYSIS; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; HEALTH CARE COSTS; HUMANS; MODELS, ECONOMETRIC; PHARMACEUTICAL PREPARATIONS; POINT-OF-CARE SYSTEMS; PREVALENCE; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 55249097144     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181637417     Document Type: Article

References (88)

1. American Academy of Ophthalmology. Conjunctivitis. San Francisco, CA: American Academy of Ophthalmology; 2003.
2. National Center for Health Statistics, Ganley JP, Roberts J. Eye conditions and related need for medical care among persons 1-74 years of age, United States 1971-72. Vital Health Stastistics. Series II, No. 228. Public Health Service, Washington DC, 1983.
3. Schneider JE, Chang S, Udeh B, et al. Prevalence and Costs of Conjunctivitis in the Commercially Insured Market. Working Paper in Review. Morristown, NJ: Health Economics Consulting Group LLC; 2007.
4. Silverman M, Bessman E. Conjunctivitis. Available at: http://www.emedicine.com/emerg/topic110.htm. Accessed January 20, 2006.
5. Shields T, Sloane PD. A comparison of eye problems in primary care and ophthalmology practices. Fam Med 1991; 23:544-46.
6. Royal College of General Practitioners and Royal College of Ophthalmologists. Ophthalmology for general practice trainees. London: Medical Protection Society; 2001.
7. Wilson A. The red eye: a general practice survey. J R Coll Gen Pract 1987;37:62-4.
8. Dart J. Eye disease at a community health centre. Br Med J 1986;293:1477-80.
9. McDonnell P. How do general practitioners manage eye disease in the community? Br J Ophthalmol 1988;72:733-76.
10. Sheldrick J, Vernon S, Wilson A. Study of diagnostic accord between general practitioners and an ophthalmologist. Br Med J 1992;304:1096-98.
11. Sheldrick J, Wilson A, Vernon S, et al. Management of ophthalmic disease in general practice. Br J Gen Pract 1993; 43:459-62.
12. Chen C, Wu K, Hsu M, et al. Prevalence and relationship between allergic diseases and infectious diseases. J Microbiol Immunol Infect Dis 2001;34:57-62.
13. Royal College of General Practitioners, Ophthalmologists RCo. Ophthalmology for general practice trainees. London: Medical Protection Society; 2001.
14. Koopman C, Pelletier K, Murray J, et al. Stanford Pre-senteeism Scale: Health Status and Employer Productivity. J Occup Environ Med 2002;44: 14-20.
15. American Optometric Association. Care of the patient with conjunctivitis. St Louis: American Optometric Association; 2002.
16. Folland S, Goodman AC, Stano M. The economics of health and health care. New Jersey (NJ): Prentice Hall; 2001.
17. Gold MR, Seigel JE, Russell LF, et al. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996.
18. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
19. Rietveld RP, van Weert HC, ter Riet G, et al. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. Br Med J 2003; 327:789.
20. Little P, Gould C, Williamson I, et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. Br Med J 1997;315:350-52.
21. College voor zorgverzekeringen. Genees en Hulpmiddelen Informatie Project. Amstelveen: College voor Zorgverzekerin-gen; 2001.
22. Department of Health. Prescription cost analysis data. Leeds: Department of Health; 1998.
23. Piednoir E, Bureau-Chalot F, Merle C, et al. Direct costs associated with a nosocomial outbreak of adenoviral conjunctivitis infection a long-term care institution. Am J Infect Control 2002;30:407-10.
24. Srinivasa DK, D'Souza V. Economic aspects of an epidemic of haemorrhagic conjunctivitis in a rural community. J Epidemiol Community Health 1987;41:79-81.
25. Lairson DR, Begley CE, Reynolds TF, et al. Prevention of herpes simplex virus eye disease - a cost-effectiveness analysis. Arch Ophthalmol 2003;121:108-12.
26. Pitt AD, Smith AF, Lindsell L, et al. Economic and qual-ity-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004;11:17-33.
27. Smith AF, Pitt AD, Rodruiguez AE, et al. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol 2005;12:233-42.
28. Darougar S, Woodland R, Walpita P. Value and cost effectiveness of double culture tests for diagnosis of ocular viral and chlamydial infections. Br J Ophthalmol 1987;71: 673-75.
29. Drummond MF, McGuire A. Economic evaluation in health care: merging theory with practice. New York (NY): Oxford University Press; 2001.
30. Medstat. MarketScan Commercial Claims and Encounters Database; 2006.
31. U.S. Central Intelligence Agency. CIA - World Factbook; 2006. Available at: https://cia.gov/cia/publications/factbook/.
32. Manners T. Managing eye conditions in general practice. Br Med J 1997;315:816-17.
33. Medstat. MarketScan Commercial Claims and Encounters Database; 2006.
34. Garrity J, Liesegang T. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984;19:21-4.
35. Rich L, Hanifin J. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 1985;25:61-76.
36. Ronnerstam R, Persson K, Hansson H, et al. Prevalence of chlamydial eye infection patients attending an eye clinic, a VD clinic, and in healthy persons. Br J Ophthalmol 1985;69: 385-88.
37. Stenberg K, Mardh PA. Genital infection with Chlamydia trachomatis in patients with chlamydial conjunctivitis: unexplained results. Sex Trans Dis 1991;18:1-4.
38. Rose PW, Hamden A, Brueggemann AB, et al. Chloram-phenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 2005;366:37-43.
39. Gallenga P, Lobefalo L, Colangelo L, et al. Topical lome-floxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind phase III study. Opthalmologica 1999;213:250-57.
40. Horven I. Acute conjunctivitis: a comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol 1993;71:165-68.
41. Miller I, Wittreich J, Vogel R, et al. The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. Eur J Ophthalmol 1992;2: 58-66.
42. Rietveld RP, ter Riet G, Bindels PJE, et al. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. Br Med J 2004;329:206B-208B.
43. Stenson S, Newman R, Fedukowicz H. Laboratory studies in acute conjunctivitis. Arch Ophthalmol 1982;100: 1275-77.
44. Gigliotti F, Williams WT, Hayden FG. Etiology of acute conjunctivitis in children. J Pediatr 1981;98:531-36.
45. Fitch CP, Rapoza PA, Owens S. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology 1989;96:1215-20.
46. Weiss A, Brinser J, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr Med 1993;122:10-14.
47. Ishii K, Nakazono N, Fujinaga K. Comparative studies in aetiology and epidemiology of viral conjunctivitis in three countries in East Asia - Japan, Taiwan and South Korea. Int J Epidemiol 1987;16:98-103.
48. Porter JD, Teter M, Traister V, et al. Outbreak of adeno-viral infections in a long-term paediatric facility, New Jersey, 1986/87. J Hosp Infect 1991;18:201-10.
49. Stanek J, Kunzova K, Svobodova E, et al. A nosocomial epidemica caused by adenovirus type 3 at a clinic for children and adolescents. Cesk Epidemiol Mikrobiol Imunol 1989;38: 193-98.
50. Foy HM, Cooney MK, Hatlen JB. Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool. Arch Environ Health 1968;17:795-802.
51. Crabtree PA, Berba KD, Rosse CP, et al. Waterborne adenovirus: a risk assessment. Water Sci Technol 1997;35: 1-6.
52. Harley D, Harrower B, Lyon M, et al. A primary school outbreak of pharyngoconjuncitval fever caused by adenovirus type 3. Commun Dis Intell 2001;25:9-12.
53. Martone WJ, Hierholzer JC, Keenlyside RA et al. Outbreak of adenovirus type-3 disease at a private recreation center swimming pool. Am J Epidemiol 1980;111:229-37.
54. Richmond S, Burman R, Crosdale E, et al. A large outbreak of keratoconjunctivitis due to adenovirus type 8: report on a large outbreak. J Hyg (Lond) 1984;93:285-91.
55. Colon LE. Keratoconjunctivitis due to adenovirus type 8: report on a large outbreak. Ann Ophthalmol 1991;23:63-65.
56. Expert Opinion. Data on conjunctivitis treatment patterns. Health Economics Consulting Group LLC, Editor; 2006.
57. D'Angelo LJ, Hierholzer J, Keenlyside RA, et al. Pha-ryngoconjunctival fever caused by adenovirus type 4: report of a swimming pool-related outbreak with recovery of virus from pool water. J Infect Dis 1979;140:42-47.
58. Mahajan VM. Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol 1983;67:191-94.
59. Okkes I, Oskam S, Lamberts H. Van Klacht Naar Diagnose: Episodegegevens uit de Huisartspraktijk. Bussum: Coutinho; 1998.
60. Van der Werf G, Smit R, Stewart R, et al. Spiegel Op de Huisarts: Over Registratie Van Ziekte, Medicatie en Verwi-jzing in de Geautomatiseerde Huisartspraktijk. Groningen: Rijksuniversiteit Groningen; 1998.
61. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract 2001;51: 473-477.
62. Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract 2002;19: 658-60.
63. Oklahoma Medical Research Foundation. Health policy brief: vision care in Oklahoma. Tulsa: Center for Health Policy Research; 1991.
64. Lohr J. Treatment of conjunctivitis in infants and children. Pediatr Ann 1993;22:359-64.
65. Barnard DL, Hart JCD, Marmion MJ, et al. Outbreak in Bristol of conjunctivitis caused by adenovirus type 8, and its epidemiology and control. Br Med J 1973;2:165-69.
66. Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea 2006;25:199-202.
67. Jackson WB, Davis PL, Groh V, et al. Adenovirus type 19 keratoconjunctivitis in Canada. Can J Ophthalmol 1975;10: 326-33.
68. Lichtenstein SJ, Rinehart M. Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. J Aapos 2003;7:317- 324.
69. Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician 1998;57:735-46.
70. Shields S. Managing eye disease in primary care. Part 2. How to recognize and treat common eye problems. Postgrad Med 2000;108:83-86, 91-86.
71. Waly AM. New management of epidemic viral keratoconjunctivitis. Internet J Ophthalmol Visual Sci 2005;3. Available at: http://www.ispub.com/ ostia/index.php?xmlFilePath= journals/ijovs/vol3n2/viral.xml. Accessed August 4, 2008.
72. Yetman R, Coody D. Conjunctivitis: a practice guideline. J Pediatr Health Care 1997;11:238-41.
73. Red Book. 2003 Report of the Committee on Infectious Diseases, Vol. 142, 26th ed. American Academy of Pediatrics; 2003.
74. Roba L, Kowalski R, Romanowski E. How long are patients with epidemic keratoconjunctivitis infectious? Invest Ophthalmol Vis Sci. 1993;34:848.
75. Leibowitz HM. The red eye. N Engl J Med. 2000;343:345-51.
76. Steinkuller P, Edmond J, Chen R. Ocular infections. In: Feigin R, Cherry J, editors. Textbook of pediatric infectious diseases, 4th ed. Philadelphia: WB Saunders;1998:786-806.
77. Weber CM, Eichenbaum JW. Acute red eye - differentiating viral conjunctivitis from other, less common causes. Postgrad Med 1997;101:185-86.
78. Physicians Desk Reference. Physician's desk reference, 56th ed. Montvale, NJ: Medical Economics Company; 2002.
79. Dawson C, Darnell R. Infection due to adenovirus type 8 in the United States: an outbreak of epidemic keratoconjuncti-vitis originating in a physician's office. N Engl J Med 1963; 268:1301-1304.
80. Cockburn TA, Nitowsky H, Robinson T. Epidemic kera- toconjunctivitis: a study of a small epidemic. Am J Ophthal-mol 1953;36:1367-72.
81. Pavan-Langston D. Viral diseases of the cornea and external eye. In: Albert D, Jakobiec A, Robinson N, editors. Principles and practice of ophthalmology. Philadelphia: The W.B. Saunders Company;1994:149-152.
82. Sambursky R, Tauber S, Schirra F, et al. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology 2006;113:1758-64.
83. Rapid Pathogen Testing. Rapid pathogen testing - pricing. Available at: www.rps-tests.com. Accessed January 2006.
84. Medical Group Management Association. Cost survey. Engle-wood, Colorado: Medical Group Management Association; 1998.
85. Bureau of Labor Statistics. Consumer price indexes. Available at: http://www.bls.gov/cpi/, 2006. Accessed January 2006.
86. Fleming T. Red book. Montvale, NJ: Thomson; 2005.
87. Drugstore.com. Available at: www.drugstore.com, 2006. Accessed January 2006.
88. Bureau of Labor Statistics. Relative pay rates among census divisions and occupational groups. Available at: http://www. bls.gov/opub/cwc/ cm20030814ar01p1.htm, 2006.